Status:
TERMINATED
Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review
Lead Sponsor:
University of New Mexico
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
1.11 Retrospectively evaluate for a correlation between tumor response and changes in systolic/diastolic/mean arterial blood pressures in patients treated with bevacizumab, with or without chemotherap...
Detailed Description
This study is a retrospective chart review of all patients with metastatic cancer of any type treated with bevacizumab(with or without chemotherapy) at the University of New Mexico Cancer Research \& ...
Eligibility Criteria
Inclusion
- Patients treated with bevacizumab, with or without chemotherapy, with a wide variety of metastatic malignancies.
- Patients with and without pre-existing hypertension treated with bevacizumab plus or minus chemotherapy with a wide variety of metastatic malignancies.
Exclusion
- Not specified.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00322725
Start Date
February 1 2006
End Date
April 1 2009
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Mexico
Albuquerque, New Mexico, United States, 87131